J & J Pledges 400 Million Covid-19 Vaccines to Africa

Johnson & Johnson says it’s agreed to provide up to 400 million doses of its one-dose COVID-19 vaccine to African countries, starting this summer.

The pharmaceutical company under its agreement with the African Vaccine Acquisition Trust, noted the company will provide up to 220 million vaccine doses for the African Union’s 55 member states, and delivery will begin in the third quarter of 2021.

Advertisement

South African pharmaceutical company Aspen Pharmacare, a part of J&J’s global supply and manufacturing network for its vaccine, will support vaccine shipments to the African Union.

On March 12, the Johnson & Johnson vaccine was approved by World Health Organization for emergency use, paving the way for the one-shot dose to be used as part of the United Nation’s international vaccine distribution effort.

Respective regulatory bodies within the continent still have to give their nods for the vaccine to be used in their countries.

Author

  • Deborah Akwa

    Deborah Akwa is a content writer with over four years of experience creating brand stories, editorial content, and audience-focused articles on topics like health, lifestyle, and entertainment.

    When she isn't writing, she is behind the scenes managing editorial operations and helping the content team work better.

    She loves using words to connect brands with their audiences. Outside of work, she enjoys watching movies and engaging in thought-provoking conversations.

Share the Story
Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement

Keep Up to Date with the Most Important News

Weekly roundups. Sharp analysis. Zero noise.
The NewsCentral TV Newsletter delivers the headlines that matter—straight to your inbox, keeping you updated regularly.